Methods, compositions and kits relating to chitinases and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S141100, C424S146100, C530S387900, C530S388260

Reexamination Certificate

active

10202436

ABSTRACT:
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g., asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic rhinitis, scleroderma, and the like), relating to inhibiting a chitinase-like molecule. The invention further includes methods to identify new compounds for the treatment of inflammatory disease, including, but not limited to, asthma, COPD and the like. This is because the present invention demonstrates, for the first time, that expression of IL-13, and of a chitinase-like molecule, mediates and/or is associated with inflammatory disease and that inhibiting the chitinase-like molecule treats and even prevents, the disease. Thus, the invention relates to the novel discovery that inhibiting a chitinase-like molecule treats and prevents an inflammatory disease.

REFERENCES:
patent: 5070191 (1991-12-01), Yamada
patent: 5413991 (1995-05-01), Yamada
patent: 6844179 (2005-01-01), Nakanishi et al.
patent: 2003/0087414 (2003-05-01), Aerts et al.
patent: 2005/0163767 (2005-07-01), Nakanishi et al.
patent: 1 231 270 (2000-09-01), None
patent: WO 0136633 (2001-05-01), None
patent: WO 02/23991 (2002-03-01), None
Clark, M. “Antibody humanization: a case of the ‘Emperor's new clothes’?” (2000) immunology Today, 21:397-402.
The Merck Manual of Diagnosis and Therapy, 17thed, 1999, eds. Beers and Berkow, Merck Research Laboratoroies, pp. 601-616.
Genbank sequence AF290003, Feb. 27, 2001, pp. 1-2.
Genbank sequence AF290004, Feb. 27, 2001, pp. 1-2.
Campbell, A. M., Monoclonal Antibody Technology, 1984, Elsevier Science Publishing Company Inc., pp. 1-32.
The Merck Manual, 17thedition, 1999, editors Beers and Berkow, Merck Research Laboratories, pp. 568-583.
Bleau et al., 1999, EXS 87:211-221.
Boot et al., 1998, J. Biol. Chem. 273:25680-25685.
Boot et al., 2001, J. Biol. Chem. 276:6770-6778.
Bradding et al., 1994, Am. J. Respir. Cell Mol. Biol. 10:471-480.
Chang et al., 2001, J. Biol. Chem. 276:17497-17506.
Elias et al., 1999, J. Clin. Invest. 104:1001-1006.
Funke et al., 1989, Comp. Biochem Physiol. 94B:691-695.
Gossen et al., 1995, Science 268:1766-1769.
Grünig et al. 1998, Science 282:2261-2263.
Guo et al., 2000, J. Biol. Chem. 275:8032-8037.
Guoping et al., 1997, J. Cell. Biochem. 67:257-264.
Hamelmann et al. 1997, Am. J. Resp. Crit. Care Med. 156:766-775.
Hamid et al., 1991, J. Clin. Invest. 87:1541-1546.
Heinzmann et al., 2000, Hum. Mol. Genet. 9:549-559.
Izumida et al., 1995, J. Mar. Biotechnol. 2:163-166.
Izumida et al., 1996, J. Antibiotics 49:76-80.
Jin et al., 1998, Genetics 54:316-322.
Kato et al., 1995, Tetrahedron. Lett. 36:2133-2136.
Kotsimbos et al., 1996, Proc. Assoc. Am. Physicians 108:368-373.
Nicolaides et al., 1997, Proc. Natl. Acad. Sci. USA 94:13175-13180.
Nishimoto et al., 1991, J. Antibiotics 44:716-72.
Owhashi et al., 2000, J. Biol. Chem. 275:1279-1286.
Ray et al. 1997, J. Clin. Invest. 100:2501-2511.
Ray et al., 1999, J. Clin. Invest. 104:985-993.
Seferian et al., 2000, Vaccine 19:661-668.
Shibata et al., 2000 J. Immunol. 164:1314-1321.
Snol et al, 2000, J. Clin. Invest. 105:1027-1030.
Ward et al., 2001, Am. J. Pathol. 158:323-332.
Webb et al., 2001, J. Biol. Chem. 276:41969-41976.
Wills-Karp, 1998, Science 282:2258-2260.
Xu et al., 1997, Lancet 350:1431-1434.
Yang et al. 1998, J. Exp. Med. 188:1739-1750.
Zhou et al, 1993, J. Antibiotics 46:1582-1588.
Zhu et al. 1999, J. Clin. Invest. 103:779-788.
Vestbo et al., “Update on the ‘Dutch hypothesis’ for chronic respiratory disease”, Thorax, 53(Suppl. 2): S15-S19 (1998).
Fülöp and Falus, “Possibilities and results in the wide-scale genomic analysis of inflammation,” Inflammation Research, 53:517-522 (2004).
Lindsay, Mark “Target discovery,” Nature Reviews, 2:831-838(2003).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods, compositions and kits relating to chitinases and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods, compositions and kits relating to chitinases and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, compositions and kits relating to chitinases and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3760005

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.